Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Schrödinger, Inc.

Clinical trials sponsored by Schrödinger, Inc., explained in plain language.

Schrödinger, Inc. SDGR NASDAQ

Computational drug discovery software and services company.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Terminated 1

Experimental drug SGR-2921 tested for tough blood cancers – but trial halted early

Disease control Terminated

This early-stage trial tested an experimental oral drug called SGR-2921 in adults with relapsed or refractory acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS). The main goals were to check safety and find the right dose. However, the study was terminated e…

Phase: PHASE1 • Sponsor: Schrödinger, Inc. • Aim: Disease control

Last updated Jun 27, 2026 07:51 UTC